Physician profile
Lucy L Chen
NPI 1174865430
$8,084.69
in general payments reported to CMS, 2019-2025
33 companies · $1,972 in 2025
The $1,972 reported for 2025 was more than what 75% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $800 · 2020: $121 · 2021: $326 · 2022: $1,201 · 2023: $2,206 · 2024: $1,458 · 2025: $1,972.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,556 · Education: $79.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,556.44 |
| Education | $79.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,688.78 | 2019-2025 | Botox, Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $910.87 | 2021-2025 | Tremfya |
| Allergan, INC. | $745.78 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $555.34 | 2019-2025 | Absorica Ld, Winlevi |
| Regeneron Healthcare Solutions, INC. | $472.67 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $469.24 | 2019-2025 | |
| Lilly USA, LLC | $432.87 | 2022-2025 | Taltz, Ebglyss, Olumiant |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $386.85 | 2019-2025 | Jublia, Arazlo, Cabtreo |
| Pfizer INC. | $360.09 | 2019-2025 | |
| Ucb, INC. | $259.27 | 2022-2025 | Bimzelx, Cimzia |
| Galderma Laboratories, L.P. | $239.25 | 2020-2025 | |
| Organon LLC | $209.16 | 2025 | |
| Genzyme Corporation | $208.19 | 2022-2025 | |
| Organogenesis INC. | $202.44 | 2023-2025 | Puraply, Puraply Wound Matrix |
| Merz North America, INC. | $197.55 | 2019-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Scientific Affairs, LLC | $103.47 | 2019 | |
| Incyte Corporation | $83.04 | 2024-2025 | Opzelura |
| Celgene Corporation | $78.74 | 2019 | |
| Leo Pharma INC. | $64.80 | 2025 | Adbry, Spevigo |
| Smith+Nephew, INC. | $60.10 | 2024-2025 | Collagenase Santyl, Pico 14 |
| Revance Therapeutics, INC. | $52.05 | 2024 | Daxxify |
| Medtronic, INC. | $46.34 | 2025 | Closurefast |
| Kerecis Limited | $41.96 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Clozex Medical INC | $39.47 | 2022 | |
| Verrica Pharmaceuticals INC. | $39.23 | 2025 | Ycanth |
| Boehringer Ingelheim Pharmaceuticals, INC. | $26.29 | 2025 | Spevigo |
| Arcutis Biotherapeutics, INC. | $20.49 | 2023 | |
| Acera Surgical, INC. | $19.54 | 2022 | |
| Dusa Pharmaceuticals, INC. | $15.73 | 2019 | |
| Biofrontera INC. | $14.41 | 2019 | |
| Mimedx Group, INC. | $14.18 | 2025 | |
| Helsinn Therapeutics (U.S.), INC. | $13.74 | 2025 | Valchlor |
| Strata Skin Sciences, INC. | $12.76 | 2023 | Xtrac |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lucy Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.